[1]
Telia , A. et al. 2021. EFFICACY, SAFETY AND COST-EFFECTIVENESS OF SUBLINGUAL IMMUNOTHERAPY IN ASTHMA. Collection of Scientific Works of Tbilisi State Medical University. 55, (Feb. 2021), 73–77.